Prescription Drugs - Dinner to Save America

​💊 Should the U.S. Government Control Prescription Drug Prices?

​America pays more for prescription drugs than any other country. A single vial of insulin can cost $300 here and $30 in Canada. On one side, critics argue that pharma companies exploit regulatory loopholes to set monopoly prices, harming patients and the system alike. On the other, defenders warn that aggressive price controls could kill innovation, especially for high-risk drugs that may never reach the market.

​So what’s the right balance between access and advancement?

1. ​What do we owe the sick?
   Should life-saving drugs be treated like public utilities, even if that kills private incentives?

2. ​Is the current model rigged?
   Between patent evergreening, pharmacy benefit managers, and nonprofit hospital markups, where is the real margin — and who’s gaming the system?

3. ​Can we afford what’s coming?
   As breakthrough drugs for cancer, Alzheimer’s, and gene therapy reach market with $1M+ price tags, is the system prepared — or doomed?